Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 801–900 of 942
The Gut Microbiota and Effects on Metabolism
Hussey, S. E., & Bergman, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.02009-8 · Cited by 9
The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
Yaghmaei, H., Nojoumi, S. A., Soltanipur, M., Yarmohammadi, H., Mirhosseini, S. M., Rezaei, M., Nadoushan, M. J., & Siadat, S. D. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100551 · Cited by 7
Synergistic effect rescue animal model from NASH caused by diet-inflammation inducer
Furlan, C. P. B., Batista, P. B., Kido, L. A., Duft, R. G., Cavaglieri, C. R., Carvalho, P. D. O., & Maróstica, M. R. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113562 · Cited by 6
Menghini, R., Hoyles, L., Cardellini, M., Casagrande, V., Marino, A., Gentileschi, P., Davato, F., Mavilio, M., Arisi, I., Mauriello, A., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101454 · Cited by 9
“Multivariate modelling was performed using O-PLS-DA as previously reported [19,20].”
MethodSelf-citationHepatocellular Cancer and Gut Microbiome: Time to Untie Gordian’s Knot
Aygün, C., & Tozun, N. A. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00736-5 · Cited by 7
“The most important metabolites related to liver disease can be summarized as (1) bile acids such as deoxycholic acid (DCA) and lithocholic acid (LCA) which are involved in digestive processes or represent etiological agents and mediators of the inflammatory process [5, 6]; (2) choline, which is involved in the transpo…”
BackgroundBian, H., Wu, Z., Bao, B., Cai, J., Wang, X., Jiang, Y., Liu, J., & Qu, W. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1211713 · Cited by 9
“Meanwhile, HFD-fed mice had a higher conversion of choline to methylamine than LFD-fed mice (Dumas et al. 2006).”
BackgroundLu, J., Fang, B., Ren, M., Huang, G., Zhang, S., Wang, Y., Deng, X., & Guan, S. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.04.007 · Cited by 6
Diet Induced Inflammation and Potential Consequences on Fetal Development
Rajkumar, H. (2013) · Journal of Nutritional Disorders & Therapy · doi:10.4172/2161-0509.1000125 · Cited by 6
“This may eventually promote fatty liver, insulin resistance and lipid peroxidation and inflammation [28].”
BackgroundThe emerging role of the microbial-gastrointestinal-neural axis
McLean, P. G., Calver, A. R., Alpers, D., Collins, S. M., Shanahan, F., & Lee, K. (2009) · Gastroenterology Insights · doi:10.4081/gi.2009.e3 · Cited by 6
“been shown to have an influence on glucose tolerance(21) and development of fatty liver disease.(22) Also, in alcoholic cirrhosis, the erosive”
BackgroundDebugging the intestinal microbiota in IBD
Dessein, R., Rosenstiel, P. C., & Chamaillard, M. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(09)73148-3 · Cited by 5
“steatosis of the liver and insulin resistance) are linked to certain prokaryotes constituting the fl ora, which control metabolic function by extracting energy from the diet [25, 26].”
BackgroundPers, T. H., Martin, F., Verdich, C., Holst, J. J., Johansen, J. V., Astrup, A. V., Polak, J., Martínez, J. A., Rezzi, S., Blaak, E. E., et al. (2008) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2008.03.008 · Cited by 10
Theranostics Approaches to Gastric and Colon Cancer
Raju, S., & Bhaskar, L. (2020) · doi:10.1007/978-981-15-2017-4 · Cited by 6
Cholesterol Regulation by Leptin in Alcoholic Liver Disease
Vairappan, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00015-x · Cited by 8
Dumas, M., & Gauguier, D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1689-0_14 · Cited by 10
Self-citationThe major biogenic amine metabolites in mood disorders
Yang, H. J., Yuan, M., & Zhang, W. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1460631 · Cited by 8
Jiang, Y., Chowdhury, S., Xu, B., Meybodi, M. A., Damiris, K., Devalaraju, S. S., & Pyrsopoulos, N. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1777 · Cited by 6
Effect of long-term antibiotic use on weight in adolescents with acne
Contopoulos‐Ioannidis, D. G., Ley, C., Wang, W., Ma, T., Olson, C., Shi, X., Luft, H. S., Hastie, T. J., & Parsonnet, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv455 · Cited by 6
Siddiqui, M. B., Siddiqui, M. S., & Sanyal, A. J. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch10
Proteomic analysis of homocholine catabolic pathway in Pseudomonas sp. strain A9
Ahmed, I. A. M., Eltayeb, M. M., Mori, N., Arima, J., TANAKA, H. K. M., Taniguchi, T., & Yamanaka, N. (2015) · Process Biochemistry · doi:10.1016/j.procbio.2015.07.001 · Cited by 5
Dynamic changes in metabolic profiles of rats subchronically exposed to mequindox
Jiang, L., Zhao, X.-J. G., Huang, C., Lei, H., Tang, H., & Wang, Y. (2014) · Molecular BioSystems · doi:10.1039/c4mb00218k · Cited by 9
Metabolic Syndrome and Obesity in Adults
Power, S. E., Fitzgerald, G. F., O’Toole, P. W., Ross, R. P., Stanton, C., Quigley, E. M. M., & Murphy, E. F. (2013) · World review of nutrition and dietetics · doi:10.1159/000345750 · Cited by 5
Metabolomics of Diet‐related Diseases
Erazo, M., García, A., Rupérez, F. J., & Barbas, C. (2013) · Wiley eBooks · doi:10.1002/9781118537282.ch16 · Cited by 6
Sarafian, M. H., Ding, N. S., Holmes, E. C., & Hart, A. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00028-8 · Cited by 12
Self-citationVegetable and Fruit Intake and the Development of Cancer
Thompson, H. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374628-3.00002-5 · Cited by 11
Zhou, H.-X., Li, T., Wang, H., Zhang, Y., Hu, Y.-T., Liu, A., & Duan, G.-Q. (2025) · Toxins · doi:10.3390/toxins17060300 · Cited by 4
“Impaired PC biosynthesis inhibits lipoprotein formation, disrupting lipid transport and potentially triggering non-alcoholic fatty liver disease (NAFLD) [27,54].”
Mechanistic Insights into Choline Degradation Catalyzed by the Choline Trimethylamine-Lyase CutC
Yang, Y., Deng, W., & Liao, R. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c01496 · Cited by 7
Bose, D., Stebliankin, V., Cickovski, T., Saha, P., Trivedi, A., Roy, S., More, M., Tuteja, A. K., Mathee, K., Narasimhan, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044245 · Cited by 4
Alamri, T., Alkhaldy, A., Gauthaman, K., Pushparaj, P. N., Moulay, M., Mirza, A., Azhar, E., Barnawi, S., Papadopoulou, G., Karamitros, T., et al. (2022) · European Review for Medical and Pharmacological Sciences · doi:10.26355/eurrev_202212_30682 · Cited by 4
Liu, W., Guo, X., Chen, Y., Tang, Y., Xiao, H., Wang, Y., Li, S., & Zhou, Z. (2022) · Aquaculture Reports · doi:10.1016/j.aqrep.2022.101096 · Cited by 5
Nonalcoholic Fatty Liver Disease
Ding, L., Oligschlaeger, Y., Shiri‐Sverdlov, R., & Houben, T. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_352 · Cited by 30
Recent Insights into Treatment of Non-Alcoholic Steatohepatitis
Chiappini, F. (2016) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/3/1/00142 · Cited by 3
Chemometrics Applied to NMR Analysis
Rusilowicz, M. J., O’Keefe, S., Wilson, J. C., & Charlton, A. J. (2014) · Wiley eBooks · doi:10.1002/9780470027318.a9300 · Cited by 7
Altered Microbiota and Their Metabolism in Host Metabolic Diseases
Yeoh, B. S., & Vijay–Kumar, M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_7 · Cited by 4
The Omics Side of Fatty Liver: A Holistic Approach for a Commonly Occurring Peripartal Disease
Vailati-Riboni, M., Palombo, V., & Loor, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-43033-1_11 · Cited by 5
Richards, S. E., & Holmes, E. C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-78242-084-2.00003-4 · Cited by 6
Self-citationProbiotics to Treat Visceral Obesity and Related Liver Disease
Vajro, P., Poeta, M., Pierri, L., Pizza, C., D’Aniello, R., Sangermano, M., Massa, G., & Paolella, G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407869-7.00033-7 · Cited by 6
A subset of UPR-induced transmembrane proteins are prematurely degraded during lipid perturbation
Ng, B. S., Shyu, P., Ho, N., Chaw, R., Sy, L., & Thibault, G. (2017) · bioRxiv · doi:10.1101/178947 · Cited by 3
“In another study, mice fed with high fat diet exhibited an increase in gut microbiota enzymatic activity that have been shown to lead to reduced choline (Dumas et al., 2006; Nicholson et al., 2012).”
BackgroundMulard, E. D., Imam, I., Coureux, P., Briolay, A., Bessueille, L., Tarby, A., Balayssac, S., Narisawa, S., Lecornu, F., Gilard, V., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08901-3 · Cited by 5
Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease
Gong, H., Zhong, H., Xu, H., Liu, X.-C., Liang-ping, L., & Zhang, D. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.011 · Cited by 3
Chai, J., Sun, Z., & Xu, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s357007 · Cited by 3
“Choline and succinic acid are metabolites produced by intestinal microorganisms.(76) Changes in the diet and gastrointestinal microbiota of women during pregnancy have a certain impact on the levels of choline and other metabolites in newborns.”
BackgroundA disease-promoting role of the intestinal mycobiome in non-alcoholic fatty liver disease
Mehal, W. Z., & Schwabe, R. F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.035 · Cited by 3
Gudan, A., & Stachowska, E. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0019 · Cited by 5
A metabolomics pipeline enables mechanistic interrogation of the gut microbiome
Han, S., Treuren, W. V. V., Fischer, C. R., Merrill, B., DeFelice, B. C., Sanchez, J.-M., Higginbottom, S., Guthrie, L., Fall, L., Dodd, D., et al. (2021) · bioRxiv · doi:10.1101/2021.05.25.445684 · Cited by 3
Fu, C., Yang, Y., Kumrungsee, T., Kimoto, A., Izu, H., & Katô, N. (2020) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.66.553 · Cited by 3
Human Microbe‐Disease Association Prediction by a Novel Double‐Ended Random Walk with Restart
Wang, D., Cui, Y., Cao, Y., He, Y., & Chen, H. (2020) · BioMed Research International · doi:10.1155/2020/3978702 · Cited by 3
The Microbial Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function
Brial, F., Alzaid, F., Sonomura, K., Meneyrol, K., Lay, A. L. L., Péan, N., Neves, A., Chilloux, J., Hedjazi, L., Sato, T.-A., et al. (2018) · bioRxiv · doi:10.1101/444893 · Cited by 3
Self-citationRole of Gut Microbiome in the Modulation of Environmental Toxicants and Therapeutic Agents
Hossain, A., Menezes, G. A., Al, M., & Ashankyty, I. (2016) · CRC Press eBooks · doi:10.1201/9781315371443-25 · Cited by 6
MicroRNAs: Decoders of Dysbiosis into Metabolic Diseases?
Sérino, M. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000698 · Cited by 2
“Indeed, both liver [19,35,36] and adipose tissue [37-39] have been shown to be specifically and deeply targeted by dysbiosis of gut microbiota, as reported above.”
BackgroundNovel Omics Technologies in Food Nutrition
Zhang, X., You, L., & Kaijun, X. (2015) · Wiley eBooks · doi:10.1002/9781118930458.ch1 · Cited by 2
Li, X., Jia, Y., Wang, J., Yang, M., Wang, K. D. G., & Kong, L. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60142-5 · Cited by 3
“, trimethylamine TMA, trimethylamine oxide TMAO, and dimethylamine DMA) by gut microbiota[27].”
Geamanu, A., Goja, A., Saadat, N., Khosla, P., & Gupta, S. V. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-55 · Cited by 2
“including toxicological effects [11,12], disease processes [13], and nutritional interventions [14,15].”
BackgroundNew Insight into Obesity and Metabolic Disease through Metabolite Profiling
Turner, N. A. (2012) · Journal of Metabonomics & Metabolites · doi:10.4172/2325-9736.1000e102 · Cited by 3
“In addition to CVD, metabolomics analyses have also implicated an active role for the intestinal microbial community in determining the susceptibility to insulin resistance and non-alcoholic fatty liver disease [20].”
BackgroundA Review of the Role of Gut microbiome in Obesity
Zhang, M. (2020) · E3S Web of Conferences · doi:10.1051/e3sconf/202021803010 · Cited by 3
Gut microbiota interaction in host lipid metabolism
Golonka, R. M., Abokor, A. A., Ntambi, J. M., & Vijay–Kumar, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00016-6 · Cited by 3
Intestinal Microbiome in Health and Disease: Introduction
Haller, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_1 · Cited by 7
Wang, Y., Zhao, L., Zou, Y., & Nie, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1775938 · Cited by 2
Li, X., Tao, Y., Li, H., Mai, L., He, X., Yan, J., & Yang, X. (2025) · Helicobacter · doi:10.1111/hel.70092 · Cited by 2
Eswaran, S., Babbar, A., Drescher, H. K., Hitch, T. C. A., Clavel, T., Muschaweck, M., Ritz, T., Kroy, D. C., Trautwein, C., Wagner, N., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147314 · Cited by 2
Brial, F., Chilloux, J., Nielsen, T., Vieira‐Silva, S., Falony, G., Hoyles, L., Neves, A. L., Rodriguez‐Martinez, A., Mouawad, G. I., Pons, N., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.15.876672 · Cited by 2
Self-citationChemometrics Applied to Nuclear Magnetic Resonance Analysis
Beavis, G., Rusilowicz, M. J., Donarski, J., Charlton, A. J., & Wilson, J. C. (2019) · Wiley eBooks · doi:10.1002/9780470027318.a9300.pub2 · Cited by 1
Fang, C., Du, H., Xiaojiao, Z., Zhao, A., Jia, W. P., & Xu, Y. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/437731 · Cited by 3
Blaise, B. J., Gouél‐Cheron, A., Floccard, B., Monneret, G., Plaisant, F., CHASSARD, D., Javouhey, É., Claris, O., & Allaouchiche, B. (2014) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2013.12.005 · Cited by 1
Metagenomics of the human microbiome
Shestakov, S. V. (2011) · Biology Bulletin Reviews · doi:10.1134/s2079086411020095 · Cited by 3
NMR Spectroscopy of Biofluids, Tissues, and Tissue Extracts
Lindon, J. C., & Holmes, E. C. (1996) · Wiley eBooks · doi:10.1002/9780470034590.emrstm0036.pub2 · Cited by 1
Self-citationMétabonomique et cartographie génétique
Gauguier, D., & Dumas, M. (2007) · médecine/sciences · doi:10.1051/medsci/200723121091 · Cited by 2
“23, décembre 2007 1091 NO UV EL LE S M AG AZ IN E alvéolaires, récemment décrites [10], semble responsable de la formation de”
BackgroundSelf-citation李, 欣. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151173 · Cited by 2
Gut Microbiota as Signatures in Non-communicable Diseases and Mucosal Immunity
Behera, S. K., Praharaj, A. B., Chalikonda, G., Srivani, G., & Mahapatra, N. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-2017-4_11 · Cited by 1
Multitasking Paneth Cells in the Intestinal Stem Cell Niche
Schewe, M., & Fodde, R. (2018) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2017.12.001 · Cited by 2
Gut microbiota and nonalcoholic steatohepatitis
Kessoku, T., Imajo, K., Kobayashi, T., Honda, Y., Ogawa, Y., Yoneda, M., Saito, S., & Nakajima, A. (2018) · Folia Pharmacologica Japonica · doi:10.1254/fpj.152.187 · Cited by 1
“Evidence supporting a role for the liver–gut axis in the pathogenesis of NASH has been slowly accumulating [104–106].”
BackgroundAhmed, I. A. M., Eltayeb, M. M., Habora, M. E. E., Eltayeb, A. E., Arima, J., Mori, N., Taniguchi, T., & Yamanaka, N. (2016) · Process Biochemistry · doi:10.1016/j.procbio.2016.10.009 · Cited by 2
The Role of Integrated Omics in Elucidating the Gut Microbiota Health Potentials
Aw, W., & Fukuda, S. (2015) · Microbiology monographs · doi:10.1007/978-3-319-23213-3_4 · Cited by 2
The Application of Toxicogenomics to the Interpretation of Toxicologic Pathology
Foster, W. R., Robertson, D. G., & Car, B. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415759-0.00011-x · Cited by 4
Role of Gut Microbiome-Host Metabolic Interactions in Metabolic Diseases
Mestdagh, R. (2012) · doi:10.25560/10003 · Cited by 2
Characterisation of the immuno-metabolic interface in porcine models of nutritional intervention
Merrifield, C. (2011) · doi:10.25560/11661 · Cited by 2
Comprehensive Metabolic Analysis for Understanding of Disease
Newgard, C. B., Stevens, R. D., Wenner, B. R., Burgess, S. C., Ilkayeva, O., Muehlbauer, M. J., Sherry, A. D., & Bain, J. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00009-x · Cited by 2
An, X., Li, C., Chai, Y., Wang, H., Yang, L., Qin, L., Soprun, L. A., Gavrilova, N., Weng, Z., Xu, J., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.06.002 · Cited by 4
Kumar, N., Keluth, S., Pandey, R., Krishnaprasad, Kovela, R. K., Mazumder, N., Srivastava, S., Vaishali, K., & Sinha, M. K. (2026) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2026.102367 · Cited by 1
Chong, S., & Ismail, I. S. (2025) · Food Safety and Health · doi:10.1002/fsh3.70024 · Cited by 1
“The decrease in betaine levels may suggest alterations in the microbiota's substrate utilization by triggering oxidative stress and activation of the inflammasome in the gut (Dumas et al. 2006), potentially leading to endothelial dysfunction (Wang et al. 2014).”
Comparative analysis of gut microbiota in healthy and diarrheic foals
Zhu, D., Li, S., Xu, Z., Kulyar, M. F., Bai, X., Wang, Y., Wang, B., Khateeb, E., Deng, D., Wang, L., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00871-24 · Cited by 2
Norris, V. (2024) · Life · doi:10.3390/life14101213 · Cited by 2
“Another benefit of the Epigenomics Project was the opportunity to interact with its guest speakers such as Marc-Emmanuel Dumas [216] and Andrew Gewirtz, which led to our proposal that the gut microbiome actually helps determine what we choose to eat [217].”
BackgroundChronic Liver Disease and Promising Therapeutic Strategy: A Concise Review
Yu, H., Wang, Z., & Zhao, G. (2024) · Pharmacognosy Magazine · doi:10.1177/09731296241228361 · Cited by 1
“Alteration of intestinal barrier in the metabolism of bile acid and choline Promotion of bacterial of pro-inflammatory cytokine production Lower abundance of Alistipes, Oscillospira, Blautia, Eubacterium, Bifidobacterium , and Coprococcus (Dumas et al., 2006).”
InfluentialArnaout, A. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/2919 · Cited by 2
“It was suggested that gut microbiota might regulate IR (30).”
BackgroundRole of Gut Microbiota in Cardiovascular Disease that Links to Host Genotype and Diet
Tun, H. M., Leung, F. C.-C., & Cheng, K. M. (2016) · InTech eBooks · doi:10.5772/64636 · Cited by 2
“These bacteria probably promote not only atherosclerosis through TMA‐TMAO production but also non‐alcoholic fatty live disease (NAFLD) by reducing choline availability for the synthesis of very low‐density lipoprotein in the liver, resulting in triglyceride accumulation in the hepatocytes [30].”
BackgroundFrom bugs to drugs—Mining the gut microbiota
Shanahan, F. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0094-8 · Cited by 1
Conduction nerveuse d’excitation sans potentiel d’action
Fasano, C., Niel, J.-P., Tercé, F., & Miolan, J.-P. (2007) · médecine/sciences · doi:10.1051/medsci/200723121075 · Cited by 3
Ledeboer, A. M., & Lähteenmäki, L. (2007) · Food Science & Technology Bulletin Functional Foods · doi:10.1616/1476-2137.14991 · Cited by 1
董, 玉. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1492516 · Cited by 1
Importance of fiber in human diet: Contribution of microbiota in human health
Farooqui, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00010-1 · Cited by 4
Cuervo-Zanatta, D., Pérez-Grijalva, B., González-Magaña, E., Hernández-Acosta, J., Murugesan, S., García-Mena, J., & Perez‐Cruz, C. (2021) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819489-8.00019-3 · Cited by 8
Microbial metabolites in nutrition and healthcare
Sundar, K., & Prabu, T. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824523-1.00012-2 · Cited by 1
Gut Microbiota and the Liver: Interaction Shaping Interactome
Devi, P., Khan, A., Chattopadhyay, P., Garg, A., & Pandey, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00080-2
Salivary and Urinary Metabolome in Pediatric Obesity and Metabolic Syndrome
Troisi, J., Marciano, F., Scala, G., Plunk, E. C., Pierri, L., & Colucci, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_19 · Cited by 2
Douzinas, E. E., & Apeiranthitis, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8946-7_23 · Cited by 1
Influence of Gut Microbiota on Hepatic Lipogenesis and Disease Pathogenesis
Singh, V., Yeoh, B. S., Ntambi, J. M., & Vijay–Kumar, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-25065-6_9 · Cited by 1
Ciber, N., Zupančič, T., Zoran, T., Šimunović, K., Pugelj, A., Papić, B., Klinec, N., Gazvoda, A., Drakslar, B., Dolenc, M., et al. (2014) · Acta agriculturae Slovenica · doi:10.14720/aas.2014.104.2.4 · Cited by 2
Authorised EU health claims for choline
Lukasik, K. V. (2014) · Elsevier eBooks · doi:10.1533/9780857098481.3.113 · Cited by 2
Martin, F., Collino, S., Rezzi, S., & Kochhar, S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-803-0_16 · Cited by 1
Gut Microbes, Immunity, and Metabolism
Hsu, E. K., & Wu, G. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_16 · Cited by 1
“Numerous diseases in both adults and children have been linked to changes in the gut microbiota, such as Helicobacter pylori in the development of stomach cancer [5], inflammatory bowel disease [6, 7], nonalcoholic fatty liver disease [ 8 ], irritable bowel syndrome [9], necrotizing enterocolitis in infants [10], and…”
BackgroundPost-Genomics Approaches towards Monitoring Changes within the Microbial Ecology of the Gut
Tuohy, K. M., Abecia, L., Deaville, E. R., Fava, F., Klinder, A., & Shen, Q. (2009) · Springer eBooks · doi:10.1007/978-0-387-79058-9_3 · Cited by 3
Rajabi, E., Seyedi, Z. P., Ghamari, M., Mohammadzadeh, R., Mansouri, M., Götz, F., & Bostanghadiri, N. (2026) · Infectious Medicine · doi:10.1016/j.imj.2026.100290
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.